Glenn Tillotson is a full-time employee of ViroPharma Incorporated, PA, USA. Alan Tice has received income for research and consulting from Replidyne, Pfizer and Astellas. This work has been ...

Shire's acquisition of Viropharma last year helped its sales and earnings rocket in 2014, although chief executive Flemming Ornskov said growth in 2015 will be slower. Full-year sales grew 23 per ...

Am J Health Syst Pharm. 2012;69(11):933-943. Based on current clinical trials reporting fewer recurrences among patients treated with fidaxomicin in which the non-NAP1/BI/027 strains were isolated ...

Shire is to pay $260 million for Lumena Pharmaceuticals, a company with a rare diseases portfolio in gastrointestinal and hepatic diseases. Shire is one of the leaders in the rare diseases field ...

Even with a "brutal" push to hit neutral cash, as one supplier described it, Vistry will also end the ...